Education
About Us
Working with TipRanks
Follow Us
AlphaTON Capital (ATON)
NASDAQ:ATON
Tt-10, Tt-4
Endometrial Cancer, Ovarian Cancer, Non Small Cell Lung Cancer, Head And Neck Squamous Cell Carcinoma, Colorectal Cancer (Crc), Renal Cell Cancer, Castrate Resistant Prostate Cancer
Phase I/II
Recruiting
TT-10 (PORT-6) and TT-4 (PORT-7) as Single Agents and in Combination in Subjects With Advanced Selected Solid Tumors
Jul 05, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does AlphaTON Capital (ATON) have in its pipeline
ATON is currently developing the following drugs: Tt-10, Tt-4. These drug candidates are in various stages of clinical development as the company works toward FDA approval.